SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ANACOR PHARMACEUTICALS
(NQNM:ANAC Last Sale: 10.56 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ANAC : $10.56)
$281 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 11/06/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus is boron chemistry platform. Have discovered, synthesized and developed five molecules that are currently in clinical development. Formerly AnaMax, Inc. Controlled by Venrock Associates. IPO at $5 November 28, 2010. Raised $60 million, selling 12 million shares, 45% of the outstanding. Lead Manager: Citigroup.
Historical Charts    Technical Analysis
No Historical Data available for ANAC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ANAC $10.56 $ 0 $10.52 $10.78 87,367 $3 $11.76 26,614
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $281,046

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex